DGRA e.V. DGRA e.V.

  • Home
  • DGRA
    • Aktuelles
    • Vorstellung
    • Geschäftsstelle
    • Vorstand
    • Mitgliederentwicklung
    • Förderung
        Walter-Cyran-Medaille DGRA-Förderpreis DGRA-Studienpreis Promotionsstipendium
    • Informationsmaterial
    • Satzung
    • Historie
  • Mitgliedschaft
    • Antrag Mitgliedschaft Firmenmitglied
    • Antrag Mitgliedschaft Privatperson
  • Fortbildungen
    • Jahreskongresse
    • Workshops
    • Lunch & Learn
    • Schools
    • AGB
  • Degree programme
    • News
    • Offered courses
        Master's degree programme Certificate course Single modules Application Student advisory service Examination board
    • In your studies
        Study plan (MDRA-27) Study modules (MDRA-27) Study modules (MDRA-26) Internship Master's thesis Lecturer Literature
    • Testimonials
    • Career perspectives
    • Press and media
    • FAQ
    • Downloads from A-Z
  • Karriere
    • Stellenangebote
    • Praktikumsangebote
  • Kontakt
  • English
    • DGRA
        Business Office Board of Directors Articles of Association
    • Awards and Scholarship
        Walter Cyran Award DGRA Award DGRA Study Award DGRA Doctoral Scholarship Lorenz Scholarship
    • Membership
        Application membership companies Application membership private individuals
    • Information Material
    • Contact
  • Home
  • DGRA
    • Aktuelles
    • Vorstellung
    • Geschäftsstelle
    • Vorstand
    • Mitgliederentwicklung
    • Förderung
        Walter-Cyran-Medaille DGRA-Förderpreis DGRA-Studienpreis Promotionsstipendium
    • Informationsmaterial
    • Satzung
    • Historie
  • Mitgliedschaft
    • Antrag Mitgliedschaft Firmenmitglied
    • Antrag Mitgliedschaft Privatperson
  • Fortbildungen
    • Jahreskongresse
    • Workshops
    • Lunch & Learn
    • Schools
    • AGB
  • Degree programme
    • News
    • Offered courses
        Master's degree programme Certificate course Single modules Application Student advisory service Examination board
    • In your studies
        Study plan (MDRA-27) Study modules (MDRA-27) Study modules (MDRA-26) Internship Master's thesis Lecturer Literature
    • Testimonials
    • Career perspectives
    • Press and media
    • FAQ
    • Downloads from A-Z
  • Karriere
    • Stellenangebote
    • Praktikumsangebote
  • Kontakt
  • English
    • DGRA
        Business Office Board of Directors Articles of Association
    • Awards and Scholarship
        Walter Cyran Award DGRA Award DGRA Study Award DGRA Doctoral Scholarship Lorenz Scholarship
    • Membership
        Application membership companies Application membership private individuals
    • Information Material
    • Contact
DE EN Anmelden

Masterarbeit

Sunset Clause- Implementation within the EU and its influence on regulatory strategies ***

Ines Becker-Schnoor (2008)


Language: English

The sunset clause provision was introduced into the European medicines legislation in Directive 2001/83/EC, as amended in November 2004.
Under Article 24 (4-6) of the Directive, any marketing authorisation which, within three years of being granted, is not followed by the placing on the market of the medicinal product will cease to be valid. If a product is placed on the market after initial granting of its marketing authorisation, but subsequently ceases to be on the market for a period of three consecutive years, it will also cease to be valid. Similar provisions in Regulation 726/2004 of the European Parliament and the Commission, apply to medicinal products authorised under the Centralised Procedure.
The three year period of the sunset clause starts to run from the granting of the marketing authorisation or from the day the product is taken off the market.

This thesis illustrates the implementation status of the sunset clause in the European Member States, and provides an outline of national provisions and interpretations of the law within said Member States.
On a general basis, the Member States of the European Union are in agreement on the main lines of the sunset clause provision. Nevertheless, there are some different approaches in defining the marketing status of a product and in specifying reasons that may lead to exemptions from the provision.
Almost every member state has a different implementation date for the revised legislation. Thus, the start of the three year period of the sunset clause is not consistent among the countries.
The new provision will have a high impact on regulatory strategies for new submissions and for already authorised medicinal products. Although a great amount of marketing authorisations will become invalid due to the sunset clause in the future there are several strategic alternatives to avoid the cessation of validity and to circumvent the provision.

Pages: 48

Zurück zur Übersicht
Newsletter

Melden Sie sich jetzt für unseren

Newsletter an.

Abonnieren!

DGRA e.V.

Adenauerallee 15

D-53111 Bonn

Telefon: 0228 / 368 26 46

Fax: 0228 / 368 26 47

E-Mail: info@dgra.de

Kooperationspartner

Uni Bonn

© 2025 Deutsche Gesellschaft für Regulatory Affairs e.V.

LinkedIn Datenschutz Impressum